Castleview Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-44
Closed -$10.2K 247
2024
Q4
$10.2K Buy
+44
New +$10.1K 0.01% 578
2022
Q1
Sell
-11,423
Closed -$50 764
2021
Q4
$50 Buy
+11,423
New +$2.51M ﹤0.01% 884

Other funds holding CME

Castleview Partners's CME Position: Q1 2025 in Review

Castleview Partners sold out of CME Group (CME) in Q1 2025, closing a stake of 44 shares — an estimated $10.2K sold.

Castleview Partners first reported a position in CME in Q4 2021 and held it in 2 quarters. The position peaked at $10.2K in Q4 2024. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.

  • Castleview Partners reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
  • Castleview Partners sold 44 CME Group shares in Q1 2025, an estimated $10.2K.
  • Castleview Partners first reported a position in CME Group in Q4 2021 and held it in 2 quarters.
  • Castleview Partners's CME Group position peaked at $10.2K in Q4 2024.
  • 1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on Castleview Partners's 13F filing for Q1 2025, filed 22 Apr 2025.